A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: Preclinical cell culture studies

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 354-363

  Curtis, J E ^a   Minkin, S ^a   Minden, M D ^a   Mcculloch, E A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

AML; ATRA; Cytosine arabinoside; Growth factors; Paclitaxel

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029807207     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1912.x     Document Type: Article

References (34)

1. Berenbaum, M.C. (1989) What is synergy? Pharmacological Reviews, 41, 93-141.
2. Bhalla, I., Ibrado, A.M., Brandt, J.E., Ray, S., Huang, Y., Tang, C., Nawabi, A. & Hoffman, R. (1995)pIXY 321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells. Leukemia. 9, 1851-1856.
3. Blagosklonny, M.V., Alvarez, M., Fujo, A. & Neckers, M.N. (1996) Bcl-2 protein down-regulation is not required for differentiation of multidrug resistant HL60 leukaemia cells. Leukaemia Research, 20, 101-107.
4. Buick, R.N., Messner, H.A., Till, J.E. & McCulloch, E.A. (1979) Cytoxicity of adriamycin and daunorubicin for normal and leukemic progenitor cells of man. Journal of the National Cancer Institute. 62, 249-255.
5. Buick, R.N., Till, J.E., & McCulloch, E.A. (1977) Colony assay for proliferative blast cells circulating in myeloblastic leukaemia. Lancet. i. 862-863.
6. Curtis, J.E., Messner, H.A., Minden, M.D., Lipton, J.H., Lockwood, G.A., Tritchler, D.I., & McCulloch, E.A. (1992) High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance. Leukemia. 6, 1192-1198.
7. Curtis, J.E., Minden, M.D., Minkin, S. & McCulloch, E.A. (1995) Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors. Leukemia. 9, 396-404.
8. Estey, E., Kurzrock, R., Talpaz, M., Freireich, E., Gutterman, J. & Deisseroth, A. (1990) Use of CSFs in AML in New York. UCLA Symposium on Molecular and Cellular Biology: Acute Myelogenous Leukemia: Progress and Controversies. pp. 443-446. R. Gate, New York.
9. Fearon, E.R., Burke, P.J., Schiffer, C.A., Zehnbauer, B.A. & Vogelstein, B. (1986) Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. New England Journal Medicine, 315, 15-24.
10. Fenaux, P., Le Deley, M.C., Castaigne, S., Archambaud, E., Chomienne, C., Link, H., Guerci, A., Duater, M., Daniel, M.T. & Bowen, O. (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicentre randomized trial. Blood, 82, 3241-3249.
11. Fialkow, P.J., Singer, J.W., Raskind, W.H., Adamson, J.W., Jacobson, R.J., Bernstein, I.D., Dow, L.W., Najdeld, V. & Veith, R. (1987) Clonal development, stem-cell differentiation, and clinical remissions in acute non-lymphocytic leukemia. New England Journal of Medicine, 317, 468-473.
12. Halder, S., Chintapalli, J. & Croce, C.M. (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Research, 56, 1253-1255.
13. Hollander, M. & Wolfe, D.A. (1973) Non-paranetric Statistical Methods. Wiley. New York.
14. Hu, Z.B., Yang, G.S., Li, M., Miyamoto, N., Minden, M.D. & McCulloch, E.A. (1995) Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Leukemia, 9, 789-798.
15. Jekunen, A.P., Christen, R.D., Shalinsky, D. & Howell, S.B. (1994) Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. British Journal of Cancer. 69, 299-306.
16. Kufe, D.W. & Spriggs, D.R. (1985) Biochemical and cellular pharmacology of cytosine arabinoside. Seminars in Oncology, 12, 34-48.
17. Lan, S., McCulloch, E.A. & Till, J.E. (1978) Cytodifferentiation in the acute myeloblastic leukemias of man. Journal of the National Cancer Institute. 60, 265-269.
18. McCulloch, E.A. (1993) Stem cell renewal and determination during clonal expansion in normal and leukemic haemopoiesis. The 1993 Lewis Schiffer Memorial Lecture to the Cell Kinetics Society. Cell Proliferation. 26, 399-425.
19. McCulloch, E.A. (1994) Regulation of drug sensitivity in cultures of the blast stem cells of acute myeloblastic leukemia. Hematopoietic Growth Factors and Cytokines in Clinical Hematology: Current Aspects and Future Directions, pp. 137-147, Karger, Basel.
20. McCulloch, E.A. (1996) Regulation of drug sensitivity in acute leukemia. VI. Prognostic factors and treatment strategies. (In press).
21. McCulloch, E.A., Minden, M.D. & Curtis, J.E. (1990) The influence of growth regulation on treatment strategy for acute myelogenous leukemia. Cancer Surveys. 9, 169-198.
22. Meng-er, H., Yu-chen, Y., Shu-rong Chen, Jin-ren, C., Jia-Xiang, L., Lin, Z., Long-jun, G. & Zhen-yi, W. (1993) Use of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood, 82, 32421-3249.
23. Messner, H.A., Curtis, J.F., Minden, M.D., Tritchler, D., Lockwood, G., Takahashi, T., Lepine, J., Jamal, N., Tweeddale, M. & Wandl, U. (1987) Clonogenic hemopoietic precursors in bone marrow transplantation. Blood, 70, 1425-1432.
24. Minden, M.D., Buick, R.N. & McCulloch, E.A. (1979) Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood, 54, 186-195.
25. Nara, N., Curtis, J.E., Senn, J.S., Tritchler, D.L. & McCulloch, E.A. (1986) The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Blood, 67, 762-769.
26. Nara, N. & McCulloch, E.A. (1985) The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Blood, 65, 184-1493.
27. Rayappa, C. & McCulloch, E.A. (1993) A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside. Leukemia, 7, 992-999.
28. Rees, J.K.H. (1990) Chemotherapy of the leukemias. New Approaches to the Treatment of Leukemia (ed. by E. J. Freireich), pp. 5-77, Springer, Berlin.
29. Rowinsky, E.K., Gilbert, M.R., McGuire, W.P., Noe, D.A., Grochow, L.B., Forastiere, A.A., Ettinger, D.S., Lubejko, B.G., Clark, B., Sartorius, S.E., Cornblath, D.R., Hendricks, C.B. & Donehower, R.C. (1991) Sequences of taxol and cisplatin: a phase 1 and pharmacologic study. Journal of Clinical Oncology, 9, 1692-1703.
30. Schiff, P.B. & Horwitz, S.B. (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proceedings of the Nationl Academy of Sciences of the United States of America, 77, 1561-1565.
31. Seiter, K., Feldman, E.J., Traganos, F., Li, X., Halicka, H.D., Darzynkiewicz, Z., Lederman, C.A., Romero, M.-B. & Ahmed, T. (1995) Evaluation of in-vivo induction of apoptosis in patients with acute leukemia treated on a phase 1 study of paclitaxel. Leukemia, 9, 1961-1983.
32. Till, J.E., McCulloch, E.A. & Siminovitch, L. (1964) A stochastic model of stem cell proliferation based on the growth of spleen colony-forming cells. Proceedings of the National Academy of Sciences of the United States of America, 51, 29-36.
33. Yang, G.S., Minden, M.D. & McCulloch, E.A. (1993) Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Leukemia, 7, 1012-1019.
34. Yang, G.S., Minden, M.D. & McCulloch, E.A. (1994) Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Leukemia, 8, 2065-2075.